DE60008077D1 - Matrixprotein zusammensetzungen um apoptose zu induzieren - Google Patents

Matrixprotein zusammensetzungen um apoptose zu induzieren

Info

Publication number
DE60008077D1
DE60008077D1 DE60008077T DE60008077T DE60008077D1 DE 60008077 D1 DE60008077 D1 DE 60008077D1 DE 60008077 T DE60008077 T DE 60008077T DE 60008077 T DE60008077 T DE 60008077T DE 60008077 D1 DE60008077 D1 DE 60008077D1
Authority
DE
Germany
Prior art keywords
apoptosis
inducate
matrix protein
protein compositions
enamel matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60008077T
Other languages
English (en)
Other versions
DE60008077T2 (de
Inventor
Petter Lyngstadaas
Lars Hammarstroem
Stina Gestrelius
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Straumann AG
Original Assignee
BIORA BIOEX MALMOE AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIORA BIOEX MALMOE AB filed Critical BIORA BIOEX MALMOE AB
Application granted granted Critical
Publication of DE60008077D1 publication Critical patent/DE60008077D1/de
Publication of DE60008077T2 publication Critical patent/DE60008077T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DE60008077T 1999-03-10 2000-03-09 Matrixproteinzusammensetzungen um Apoptose zu induzieren Expired - Lifetime DE60008077T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199900336 1999-03-10
DK990336 1999-03-10
PCT/IB2000/000245 WO2000053196A1 (en) 1999-03-10 2000-03-09 Matrix protein compositions for induction of apoptosis

Publications (2)

Publication Number Publication Date
DE60008077D1 true DE60008077D1 (de) 2004-03-11
DE60008077T2 DE60008077T2 (de) 2004-12-23

Family

ID=8092394

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60008077T Expired - Lifetime DE60008077T2 (de) 1999-03-10 2000-03-09 Matrixproteinzusammensetzungen um Apoptose zu induzieren

Country Status (8)

Country Link
EP (1) EP1162985B1 (de)
JP (1) JP2002538211A (de)
AT (1) ATE258801T1 (de)
AU (1) AU2821000A (de)
DE (1) DE60008077T2 (de)
DK (1) DK1162985T3 (de)
ES (1) ES2215027T3 (de)
WO (1) WO2000053196A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1292325B1 (de) * 2000-06-20 2009-10-14 Institut Straumann AG Zusammensetzungen mit matrixproteinen zur regeneration von dentin
WO2006064381A2 (en) 2004-12-10 2006-06-22 Straumann Holding Ag Protein formulation
SE0403014D0 (sv) 2004-12-10 2004-12-10 Straumann Holding Ag New protein formulation
EP2496273B1 (de) 2009-11-02 2016-11-30 Straumann Holding AG Gereinigte emd-proteinzusammensetzung
WO2011073447A1 (en) 2009-12-18 2011-06-23 Straumann Holding Ag Emd c-depleted
KR101821842B1 (ko) 2010-10-15 2018-01-24 스트라우만 홀딩 에이쥐 Ｐｇａ를 포함하는 새로운 ｅｍｄ 제제
WO2012131412A2 (en) 2011-03-31 2012-10-04 Szabo Laszlo Gabor Pharmaceutical composition containing no, process for the preparation and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672032A (en) * 1983-11-09 1987-06-09 University Of Southern California Dental enamel production

Also Published As

Publication number Publication date
EP1162985B1 (de) 2004-02-04
JP2002538211A (ja) 2002-11-12
ATE258801T1 (de) 2004-02-15
DK1162985T3 (da) 2004-06-14
DE60008077T2 (de) 2004-12-23
EP1162985A1 (de) 2001-12-19
WO2000053196A1 (en) 2000-09-14
AU2821000A (en) 2000-09-28
ES2215027T3 (es) 2004-10-01

Similar Documents

Publication Publication Date Title
BR9811956B1 (pt) naftiridinonas e composição farmacêutica compreendendo as mesmas.
HRP950337B1 (en) Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
BRPI0207961A8 (pt) Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos.
DE69427127D1 (de) Substituierte tetra- und pentapeptid hemmstoffe der farnesyl protein transferase
TR200100054T2 (tr) Paroksetin metansülfonat
ATE411022T1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
ES2133807T3 (es) Compuestos de peptidilo y su uso terapeutico como inhibidores de metaloproteasas.
HUP0400918A3 (en) Utilization of pyrazoline derivatives in the preparation of pharmaceutical compositions for the prevention and/or treatment of proliferative cell diseases
BR0113643A (pt) Compostos de guanidinobenzamidas como agonistas de mc4-r e seus usos
NO20015516D0 (no) Preparater og anvendelser av ET743 for behandling av kreft
TR200003206T2 (tr) İndol türevleri ve patolojik hücre çoğalmasının neden olduğu habis hastalıklar ve diğer hastalıkların tedavisinde kullanımları.
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
EA200200922A1 (ru) Композиция, включающая камптотецин и производное пиримидина, для лечения рака
DE60324431D1 (de) Derivate des 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazols als antagonisten des gonadotropin freisetzenden hormons (gnrh) zur anwendung in de behandlung von geschlechtshormonellen erkrankungen, wie prostata- oder gebahrmutterkrebs
NO20020358L (no) Anvendelse av etodolac til behandling av kreft
PT1228097E (pt) Actividade antimicrobiana do primeiro grupo cationico da lactoferrina humana
BR0009170A (pt) ácidos nucléicos akt, polipeptìdeos e uso dos mesmos
DK1185279T3 (da) Midler til behandling af maligne sygdomme ved anvendelse af proteinet YB-1
ATE258801T1 (de) Matrixprotein zusammensetzungen um apoptose zu induzieren
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
NO993784D0 (no) Farmasöytiske blandinger inneholdende ibuprofen og domperidon for behandling av migrene
ZA986720B (en) Photoresponsive sunscreen compositions
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
NO952601L (no) Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaser
DE69721484D1 (de) Nukleosidderivative in kombinationspräparaten zur behandlung von hsv krankheiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INSTITUT STRAUMANN AG, BASEL, CH